Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Donor bone marrow: an alternative to immunosuppressive drugs in transplantation?

April 26, 1999

New PRIMATIZED anti-CD80 antibodies engineered at Idec

April 26, 1999

Improved antigen response to conjugate vaccine in mature vs. neonatal mice

April 26, 1999

IDEC-131, an inhibitor of B-cell activation for the treatment of autoimmune disorders

April 23, 1999

GPC and MorphoSys collaborate on human therapeutic antibody program

April 23, 1999

Inhibitors of PTKs and T-cell activation/proliferation in development at BMS

April 22, 1999

Belgian research team designs potent, irreversible and stable DPP IV inhibitors

April 21, 1999

Rodent and early human studies support feasibility of transcutaneous immunization

April 21, 1999

First CpG DNA-based immunotherapeutic enters human trials

April 20, 1999

Potential C. albicans vaccine tested in mice

April 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...